News dal mondo

23

Apr

Top Drugs at Risk of Supply Shortages

  • Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively from one country, creating systemic single-point failure risk across multiple downstream manufacturers.
  • Parenteral products dominate vulnerability (63%), reflecting complex manufacturing and thin inventories, with many drugs appearing stable at finished-dose while remaining structurally fragile upstream.

...[PharmExecutive]

18

Giu

AIFA Sistema informatico Workflow Officine Materie Prime - Ulteriore Aggiornamento tecnico 18 maggio 2026

Formati files ammessi: PDF editabile o p7m. Scansioni a 200 dpi, anche in bianco e nero, per ottimizzare...

15

Mag

US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry

We have written on this blog about FDA’s modernization agenda from several angles lately—from...

15

Mag

EU Regulators discuss new pharma legislation, AI, and more

A panel of European regulators answered questions during a town panel discussion at RAPS Euro Convergence...

15

Mag

US FDA official details top observations from QMSR inspections

The top observations identified in Form 483 reports from inspections conducted under the recently implemented...